Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1653 1675
This examiner grants 55% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 16821807 | NOVEL EUKARYOTIC CELL-FREE PROTEIN EXPRESSION SYSTEM THAT DOES NOT REQUIRE AN ARTIFICIAL ENERGY REGENERATION SYSTEM | Final Rejection | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
| 18223989 | COMPOSITIONS INCLUDING ENDOPHYTES FOR IMPROVING PLANT NUTRITION, GROWTH,AND PERFORMANCE AND METHODS OF USING THE SAME | Non-Final OA | University of Washington |
| 17997150 | METHOD FOR PRODUCING MILK LIKE PRODUCTS | Final Rejection | SOCIETE DES PRODUITS NESTLE S.A. |
| 18011430 | METHODS, COMPOSITIONS, AND PROPHYLACTICS FOR TREATING, AMELIORATING, OR PREVENTING CORONAVIRUS DISEASE (COVID-19) | Non-Final OA | The Research Foundation for the State University of New York |
| 18024955 | METHOD FOR DIAGNOSING NONALCOHOLIC STEATOHEPATITIS | Final Rejection | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY |
| 17920561 | METHOD OF REDUCING AND RECYCLING OXIDIZED FLAVIN COFACTORS | Non-Final OA | Oxford University Innovation Limited |
| 17154864 | COMPOSITIONS AND METHODS FOR TREATMENT OF OCULAR DISEASES | Non-Final OA | MOR RESEARCH APPLICATIONS LTD. |
| 18312487 | BIOLUMINESCENCE-TRIGGERED PHOTOCATALYTIC LABELING | Non-Final OA | Promega Corporation |
| 18883789 | METHOD TO INCREASE DRUG SUBSTANCE YIELD | Non-Final OA | PharmaEssentia Corporation |
| 18829438 | NON-NATURALLY OCCURING THREE-DIMENSIONAL (3D) BROWN ADIPOSE-DERIVED STEM CELL AGGREGATES, AND METHODS OF GENERATING AND USING THE SAME | Final Rejection | BioRestorative Therapies, Inc. |
| 18566290 | PEPTIDES WITH MUCIN-BINDING PROPERTIES | Non-Final OA | University of Copenhagen |
| 17818133 | Method and System for Treatment of Microorganisms during Propagation, Conditioning, Fermentation, and Preservation Using Ethyl Lauroyl Arginate and Selected Additives | Non-Final OA | KEMIN INDUSTRIES, INC. |
| 18667369 | STABLE THERMOLYSIN HYDROGEL | Non-Final OA | SMITH & NEPHEW, INC. |
| 18706302 | DETECTION, STAGING, MONITORING AND TREATING A DISEASE OR A CONDITION | Non-Final OA | SUNBIRD BIO, INC. |
| 17177591 | CELL CULTURE METHOD AND CELL CULTURE APPARATUS | Non-Final OA | NIKKISO CO., LTD. |
| 18695489 | Production of Thermoresistant Laccases Using White Rot Fungus Coriolopsis Gallica | Non-Final OA | Université Libre De Bruxelles |
| 18034080 | NOVEL ESTERASES AND USES THEREOF | Non-Final OA | CARBIOS |
| 18693468 | Reducing or Inhibiting Tissue Damage Using Hyaluronidase Administration | Non-Final OA | Med Progress, LLC |
| 18022061 | HYPERSIALYLATED IMMUNOGLOBULIN | Non-Final OA | Momenta Pharmaceuticals, Inc. |
| 18212882 | Lysis Buffers Comprising Cyanate or Thiocyanate and a Detergent | Non-Final OA | Purigen Biosystems, Inc. |
| 18035736 | MUTANT ENZYME, USE THEREOF AND PROCESS FOR PREPARING TRIPEPTIDE BY USING ENZYMATIC METHOD | Non-Final OA | SHENZHEN READLINE BIOTECH CO., LTD. |
| 18035097 | BLOOD SAMPLE TESTING METHOD USING TAXIS BEHAVIOR OF NEMATODE | Non-Final OA | Hirotsu Bio Science Inc. |
| 18295991 | TISSUE KALLIKREIN-1 FOR TREATING CHRONIC KIDNEY DISEASE | Final Rejection | DiaMedica Therapeutics Inc. |
| 18042053 | TEST METHOD FOR MILD COGNITIVE IMPAIRMENT, TEST REAGENT FOR MILD COGNITIVE IMPAIRMENT, AND METHOD FOR SCREENING THERAPEUTIC CANDIDATE SUBSTANCES FOR MILD COGNITIVE IMPAIRMENT | Final Rejection | Bioradical Research Institute Corp. |
| 18000984 | BROMELAIN PROTEASE, BROMELAIN, JACALIN-LIKE LECTIN, EXTRACT FROM THE STEM AND/OR THE FRUIT OF A PINEAPPLE PLANT, COMBINATION PREPARATION, BROMELAIN PROTEASE INHIBITOR, PROTEIN/PROTEASE MIX, AND GLYCATED BROMELAIN PROTEIN FORMED BY EXOGENOUS NON-ENZYMATIC GLYCATION, FOR USE IN THE TREATMENT OR PROPHYLAXIS OF VIRUS INFECTIONS CAUSED BY CORONAVIRUSES IN A HUMAN OR ANIMAL | Final Rejection | HELMHOLTZ-INSTITUT FÜR PHARMAZEUTISCHE FORSCHUNG SAARLAND |
| 17756352 | AGAROPHYTON CHILENSIS EXTRACT, RICH IN FREE FATTY ACIDS, AS A NUTRACEUTICAL OR NUTRITIONAL SUPPLEMENT, SUITABLE FOR MODULATING PPAR# ACTIVITY | Final Rejection | PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE |
| 17893464 | Test kit for detecting acetylcholinesterase inhibitors | Final Rejection | Dr. Franz Köhler Chemie GmbH |
| 17594084 | DUNALIELLA ALGA PREPARATION FOR PREVENTION AND/OR TREATMENT OF A NEURODEGENERATIVE DISEASE, A DISORDER ASSOCIATED WITH PROTEIN MISFOLDING AND COGNITIVE DECLINE | Final Rejection | NIKKEN SOHONSHA CORPORATION |
| 17488123 | METHODS OF SCREENING FOR MICROORGANISMS THAT IMPART BENEFICIAL PROPERTIES TO PLANTS | Non-Final OA | BioConsortia New Zealand Limited |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy